IvyRock Asset Management (HK) Ltd
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1809525
SHEUNG WAN, K3
Position in ARWR
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$438,900
-$125,415 QoQ
Shares Held
7,000
-17.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026IvyRock Asset Management (HK) Ltd holds $15,957,002 across 6 Biotechnology names. ARWR ranks #2 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LEGN |
Legend Biotech Corp
|
804,000 | $14,544,360 | |
| 2 | ARWR |
Arrowhead Pharmaceuticals, Inc.
This page
|
7,000 | $438,900 | |
| 3 | AVBP |
ArriVent BioPharma, Inc.
|
16,000 | $369,120 | |
| 4 | NTLA |
Intellia Therapeutics, Inc.
|
19,830 | $254,220 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
8,600 | $204,938 | |
| 6 | PRME |
Prime Medicine, Inc.
|
41,800 | $145,464 |
All Filings in ARWR
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $438,900 | 7,000 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $564,315 | 8,500 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $362,145 | 10,500 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||